Literature DB >> 12576973

Appropriate use of antimicrobial agents: challenges and strategies for improvement.

Michael S Niederman1.   

Abstract

The use of inadequate empirical antimicrobial therapy is common in intensive care unit patients and contributes to a number of poor outcomes. Selecting appropriate antimicrobial therapy is complicated by many factors, including the large number of agents available, the presence of resistant organisms, and the general desire among practitioners to use the most focused therapy available. An important aspect of appropriate antimicrobial use is prompt initiation of adequate empirical therapy, which has been shown to improve mortality rates in hospitalized patients with pneumonia and other serious infections. Other key strategies include streamlining antimicrobial therapy when a pathogen is identified and switching from intravenous to oral therapy when clinically indicated. In addition, antibiotic rotation (or cycling) has been evaluated in several trials as a means to minimize resistance. Promoting appropriate antimicrobial therapy ultimately will require a multidisciplinary, system-oriented, institution-specific approach because each intensive care unit has its own unique flora and antimicrobial resistance patterns.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576973     DOI: 10.1097/01.CCM.0000050464.70382.D6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.

Authors:  Jean Chastre
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

Review 2.  [Tarragona strategy--appropriate antibiotic therapy in the ICU].

Authors:  L Engelmann; D V Schmitt
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-03-22       Impact factor: 0.840

3.  A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.

Authors:  Shiva Sarraf-Yazdi; Michelle Sharpe; Kyla M Bennett; Tim L Dotson; Deverick J Anderson; Steven N Vaslef
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

Review 4.  Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.

Authors:  Guilhem Roubaud; Bobby C Liaw; William K Oh; David J Mulholland
Journal:  Nat Rev Clin Oncol       Date:  2016-11-22       Impact factor: 66.675

Review 5.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 6.  Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time.

Authors:  Marin Kollef
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

8.  Impact of Antibiotic Stewardship Program on Prescribing Pattern of Antimicrobials in Patients of Medical Intensive Care Unit.

Authors:  Nishal Shah; Anuradha Joshi; Barna Ganguly
Journal:  J Clin Diagn Res       Date:  2017-07-01

9.  Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis.

Authors:  Catia Cillóniz; Santiago Ewig; Miquel Ferrer; Eva Polverino; Albert Gabarrús; Jorge Puig de la Bellacasa; Josep Mensa; Antoni Torres
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

Review 10.  Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice.

Authors:  Alessio Buonavoglia; Patrizia Leone; Antonio Giovanni Solimando; Rossella Fasano; Eleonora Malerba; Marcella Prete; Marialaura Corrente; Carlo Prati; Angelo Vacca; Vito Racanelli
Journal:  Antibiotics (Basel)       Date:  2021-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.